StockData

Femasys Inc (FEMY) stock

FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3035% below fair value
$1.15+0.03 (+2.68%)

Close on Nov 18, 2026Market cap $9.63MP/E –Yield –

Femasys free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Femasys's free cash flow for the twelve months ending Jun 30, 2026 was -$18.07M. For fiscal 2025 it was -$19.22M. The highest annual figure on record is -$4.94M in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$19.22M–
FY2024Dec 31, 2024-$20.21M–
FY2023Dec 31, 2023-$11.42M–
FY2022Dec 31, 2022-$11.14M–
FY2021Dec 31, 2021-$8.24M–
FY2020Dec 31, 2020-$4.94M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.95M–
Q1 FY2026Mar 31, 2026-$4.22M–
Q4 FY2025Dec 31, 2025-$4.33M–
Q3 FY2025Sep 30, 2025-$5.58M–
Q2 FY2025Jun 30, 2025-$4.45M–
Q1 FY2025Mar 31, 2025-$4.86M–
Q4 FY2024Dec 31, 2024-$5.18M–
Q3 FY2024Sep 30, 2024-$5.88M–
Q2 FY2024Jun 30, 2024-$4.51M–
Q1 FY2024Mar 31, 2024-$4.63M–
Q4 FY2023Dec 31, 2023-$3.08M–
Q3 FY2023Sep 30, 2023-$2.88M–
Q2 FY2023Jun 30, 2023-$2.80M–
Q1 FY2023Mar 31, 2023-$2.66M–
Q4 FY2022Dec 31, 2022-$2.96M–
Q3 FY2022Sep 30, 2022-$2.75M–
Q2 FY2022Jun 30, 2022-$2.55M–
Q1 FY2022Mar 31, 2022-$2.87M–
Q4 FY2021Dec 31, 2021-$2.37M–
Q3 FY2021Sep 30, 2021-$1.98M–
Q2 FY2021Jun 30, 2021-$2.73M–
Q1 FY2021Mar 31, 2021-$1.16M–
Q4 FY2020Dec 31, 2020-$1.27M–
Q3 FY2020Sep 30, 2020-$862.33K–

More Femasys figures

See a number that looks wrong?